Jakarta, CNBC Indonesia – The government of Costa Rica decided to refuse the arrival vaccine Covid-19 produced by the Chinese company Sinovac. This step was taken because the country was skeptical about the vaccine’s efficacy.
Quotes CNBC International who launched Reuters, Costa Rica has openly stated that the vaccine produced by the Chinese company is not effective enough to fight Covid-19 transmission. However, it is not explained in detail the level of effectiveness of the vaccine there.
“We have decided to refuse delivery of Sinovac Biotech’s Covid-19 vaccine for now on the basis that the vaccine is not effective enough,” the country’s health authority said on Wednesday (16/6/2021).
This is quite different from the data distributed by several countries in the world. In Uruguay, a research release showed the vaccine was 90% effective in preventing infections and deaths in intensive care.
Meanwhile in Indonesia, where this vaccine is also used, the government says the vaccine, officially named CoronaVac, is 65.3% effective in inhibiting virus transmission.
The World Health Organization (WHO) has also given an emergency distribution permit for the vaccine in which CoronaVac is reported to be 51% effective in preventing post-infection symptomatic disease and preventing severe infections up to 100%.
(boss / boss)
– .
